Publications
Print PDF
Remicade Biosimilar FDA Panel Vote Shows How It Can Be Done
February 10, 2016
John T. Aquino
Life Sciences Law & Industry Report

Axinn counsel Stacie Ropka was quoted in the Life Sciences Law & Industry Report, "Remicade Biosimilar FDA Panel Vote Shows How It Can Be Done."

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.